Midgard Science

Labs / Assays & in vitro testing

TRiCBIO

Nanjing, China · tricbio.com

On your own

Free. Their own form.

Contact TRiCBIO directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

TRiCBIO provides human organoid-based research services for drug discovery, development, and collaborative disease-model studies. It works with biopharma, CRO, and research teams from Nanjing, Shanghai, and Philadelphia, with the primary R&D work based in Nanjing. Its studies focus on tumor, normal-tissue, and disease organoids, including PDO 2.0 / ALI models with immune context.

They take quote requests by email.

What they offer

  • Organoid target discovery & functional genomics

    Discover genetic dependencies through library screening in PDO 1.0 and PDO 2.0, then validate targets with tumor, microenvironment, and treatment-response readouts.

  • Target validation & mechanism studies

    Test candidate targets in human organoids through disease phenotypes, molecular changes, and treatment response.

  • Mechanism & biomarkers

    Link tissue, functional, and molecular results to treatment response and prioritize biomarker candidates for validation.

  • Custom model development

    Develop a model and assay plan for specialized tissues, rare diseases, or complex co-cultures based on the available samples and endpoints.

  • Organoid efficacy screening

    Compare single agents and combinations in tumor PDOs and other selected human organoid models to identify dose responses and differences across models.

  • Immuno-oncology

    Evaluate immune activation and tumor-cell killing in PDO 2.0 / ALI models or immune co-cultures using tissue imaging and functional assays.

  • Antibody, multispecific & T-cell engager (TCE) studies

    Compare tumor-cell killing, immune activation, and cytokine changes for antibody, multispecific, and TCE candidates in human tumor organoids and immune co-cultures.

  • ADC research

    Combine target expression, spatial distribution, cytotoxicity, and bystander-effect readouts in an organoid study matched to the candidate ADC.

  • Safety & toxicology

    Compare dose- and exposure-related responses in relevant normal-tissue organoids using morphology, function, and injury markers to investigate organ risk.

  • Multi-organ safety in human organoids

    Compare normal kidney, lung, and GI organoids with adjacent non-tumor liver or other relevant models in a coordinated exposure design to rank organ risks.

  • Drug delivery & barrier permeability

    Assess barrier integrity, injury, and repair, then develop permeability or candidate-transport assays for the relevant tissue system.

  • Human intestinal organoid IBD-like inflammation model

    Study IBD-like inflammation in human intestinal organoids through morphology, FITC-Dextran, IL-8, and image-based candidate readouts.

  • Tailored ADPKD organoid cyst-phenotype studies

    Develop cyst-phenotype and candidate-intervention studies for autosomal dominant polycystic kidney disease using hPSC-derived kidney organoids.

  • BBB co-culture & permeability methods

    Build HUVEC–astrocyte co-culture and ZO-1 junction imaging methods with permeability, candidate-response, and transport assays.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC, Recombinant protein
Species and models
human organoids, PDO 1.0, PDO 2.0, ALI tumor-immune organoids, tumor PDOs, normal-tissue organoids, human intestinal organoid, hPSC-derived kidney organoids, HUVEC–astrocyte co-culture
Assays and studies
genetic-library screening, functional genomics, treatment-response studies, histology, flow cytometry, functional assays, H&E, IHC, IF, cytokine assays, target validation, mechanism studies, and 3 more
Instruments and platforms
flow cytometry, microscopy equipment
Therapeutic areas
immuno-oncology, drug discovery, drug development, safety, inflammation, inherited kidney disease, neurovascular-barrier research
Type
CRO
Sites
Nanjing, China · Shanghai, China · Philadelphia, US
Quality
model quality assessed through morpholog · methods, results and data sources docume
Serves
global clients

Similar labs. ACM Global Laboratories, Aurigene Pharmaceutical Services, Avance Biosciences, Axela Biosciences, Inc

Found in a contract services directory. Listing built from tricbio.com. Work here? Claim this listing.

TRiCBIO · Midgard Science